Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-23
2011-08-23
Andres, Janet (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S262000
Reexamination Certificate
active
08003797
ABSTRACT:
The present invention is directed to pyridyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
REFERENCES:
patent: 2002/0147198 (2002-10-01), Chen et al.
patent: 2009/0088452 (2009-04-01), Coleman et al.
patent: 2010/0035931 (2010-02-01), Coleman et al.
patent: 2010/0063056 (2010-03-01), Coleman et al.
patent: WO2007/061763 (2007-05-01), None
patent: WO2008/108991 (2008-09-01), None
patent: WO2010051236 (2010-05-01), None
Silverman, R. “The Organic Chemistry of Drug Design and Drug Action,” 2004, Elsevier, pp. 29-32.
Bergman Jeffrey M.
Coleman Paul J.
Fraley Mark E.
Mercer Swati P.
Reger Thomas S.
Andres Janet
Devlin Gerard M.
Merck Sharp & Dohme Corp.
Reese Heidi
Thies J. Eric
LandOfFree
Pyridine carboxamide orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine carboxamide orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine carboxamide orexin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2765256